• Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology Group 

      Fountzilas E., Lampaki S., Koliou G.-A., Koumarianou A., Levva S., Vagionas A., Christopoulou A., Laloysis A., Psyrri A., Binas I., Mountzios G., Kentepozidis N., Kotsakis A., Saloustros E., Boutis A., Nikolaidi A., Fountzilas G., Georgoulias V., Chrysanthidis M., Kotteas E., Vo H., Tsiatas M., Res E., Linardou H., Daoussis D., Bompolaki I., Andreadou A., Papaxoinis G., Spyratos D., Gogas H., Syrigos K.N., Bafaloukos D. (2022)
      Background: Data on the safety and efficacy of immune checkpoint inhibitors (ICI) in patients with concurrent autoimmune diseases (AID) are limited. Methods: We performed a retrospective multicenter review of medical records ...
    • Smoke and autoimmunity: The fire behind the disease 

      Perricone C., Versini M., Ben-Ami D., Gertel S., Watad A., Segel M.J., Ceccarelli F., Conti F., Cantarini L., Bogdanos D.P., Antonelli A., Amital H., Valesini G., Shoenfeld Y. (2016)
      The association between smoke habit and autoimmunity has been hypothesized a long time ago. Smoke has been found to play a pathogenic role in certain autoimmune disease as it may trigger the development of autoantibodies ...